JWA
TNDM icon

JFS Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

JFS Wealth Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363 Buy
24
+9
+60% +$157 ﹤0.01% 2022
2026
Q1 		$288 Hold
15
– – ﹤0.01% 1805
2025
Q4 		$330 Hold
15
– – ﹤0.01% 1841
2025
Q3 		$183 Hold
15
– – ﹤0.01% 1832
2025
Q2 		$280 Hold
15
– – ﹤0.01% 1764
2025
Q1 		$288 Hold
15
– – ﹤0.01% 1820
2024
Q4 		$541 Hold
15
– – ﹤0.01% 1767
2024
Q3 		$637 Buy
+15
New +$636 ﹤0.01% 1765

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JFS Wealth Advisors's TNDM Position: Q2 2026 in Review

JFS Wealth Advisors increased its Tandem Diabetes Care (TNDM) stake by 60% in Q2 2026, buying an estimated $157 and bringing the position to 24 shares worth $363. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

JFS Wealth Advisors first reported a position in TNDM in Q3 2024 and has held it in 8 quarters since. The position peaked at $637 in Q3 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • JFS Wealth Advisors held 24 shares of Tandem Diabetes Care worth $363 as of Q2 2026.
  • JFS Wealth Advisors bought 9 Tandem Diabetes Care shares in Q2 2026, an estimated $157.
  • Tandem Diabetes Care made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2022 holding.
  • JFS Wealth Advisors first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 8 quarters since.
  • JFS Wealth Advisors's Tandem Diabetes Care position peaked at $637 in Q3 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.